Your session is about to expire
← Back to Search
Not Applicable
Stent Placement After Ureteroscopy for Kidney Stones
N/A
Recruiting
Led By Ryan Hsi, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Nonobstructing renal stone 1.5cm total stone diameter (if multiple stones, then sum of maximum diameters) or less undergoing ureteroscopy
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline 5-10 days after ureteroscopy
Awards & highlights
Study Summary
This trial is testing whether or not a stent inserted after a surgery to remove kidney stones leads to fewer complications than not having a stent.
Who is the study for?
This trial is for adults with nonobstructing kidney stones smaller than 1.5cm in total diameter who are undergoing ureteroscopy. It's not for those under 18, pregnant, planning multiple surgeries, or with certain kidney conditions like a solitary kidney or reduced function (eGFR <60 mL/min).Check my eligibility
What is being tested?
The study aims to see if there's a difference in complications when patients receive a stent after ureteroscopy for kidney stones versus not receiving one at all.See study design
What are the potential side effects?
Potential side effects may include discomfort from the stent, urinary symptoms like frequent urination or urgency, blood in urine, and possibly increased risk of infection.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a kidney stone smaller than 1.5cm and am getting a ureteroscopy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 5-10 days after ureteroscopy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 5-10 days after ureteroscopy
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Total number of complications
Secondary outcome measures
% return to work
Cumulative opiate morphine equivalent dosing (MED)
Number of participants with abnormal imaging findings
+3 moreTrial Design
2Treatment groups
Active Control
Group I: Ureteral stent groupActive Control1 Intervention
A ureteral stent will be placed after ureteroscopy.
Group II: No ureteral stent groupActive Control1 Intervention
A ureteral stent will not be placed after ureteroscopy.
Find a Location
Who is running the clinical trial?
University of California, Los AngelesOTHER
1,530 Previous Clinical Trials
10,264,508 Total Patients Enrolled
1 Trials studying Kidney Stones
43 Patients Enrolled for Kidney Stones
Brigham and Women's HospitalOTHER
1,615 Previous Clinical Trials
11,470,630 Total Patients Enrolled
1 Trials studying Kidney Stones
43 Patients Enrolled for Kidney Stones
Penn State HealthUNKNOWN
1 Previous Clinical Trials
1,032 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have one kidney or my kidney function is reduced.I am under 18 years old.I have a kidney stone smaller than 1.5cm and am getting a ureteroscopy.I have a kidney stone in my ureter.I have an unusual kidney shape or had surgery on my urinary tract.I am scheduled for a procedure to examine both of my ureters.You currently have a tube in your kidney for draining urine.Whether or not the participant is pregnant.I have swelling of a kidney due to urine buildup before surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Ureteral stent group
- Group 2: No ureteral stent group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings for new participants in this experiment?
"Yes, the data on clinicaltrials.gov reflects that this study is recruiting candidates at this time. The initial advertisement was made on November 11th 2019 and the details were last amended on July 10th 2022 to accommodate for 200 participants across 9 research sites."
Answered by AI
How many distinct areas are handling the management of this trial?
"The trial is presently running in 9 distinct locations, including Nashville, Hershey and San Diego. Participants are encouraged to pick the closest site for their convenience, thus reducing travel requirements if one should decide to take part."
Answered by AI
What is the scope of recruitment for this clinical trial?
"Affirmative. The information published on clinicaltrials.gov demonstrates that this experiment is actively recruiting participants, with an initiation date of November 11th 2019 and a most recent update from July 10th 2022. Altogether, 200 individuals are required across 9 locations."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger